On Invalid Date, Atyr Pharma (NASDAQ: LIFE) reported Q3 2023 earnings per share (EPS) of -$0.20, up 56.52% year over year. Total Atyr Pharma earnings for the quarter were -$11.34 million. In the same quarter last year, Atyr Pharma's earnings per share (EPS) was -$0.46.
As of Q4 2023, Atyr Pharma's earnings has grown year over year. Atyr Pharma's earnings in the past year totalled -$43.15 million.
What was LIFE's revenue last quarter?
On Invalid Date, Atyr Pharma (NASDAQ: LIFE) reported Q3 2023 revenue of $353.00 thousand up Infinity% year over year. In the same quarter last year, Atyr Pharma's revenue was $0.00.
What was LIFE's revenue growth in the past year?
As of Q4 2023, Atyr Pharma's revenue has grown null year over year. Atyr Pharma's revenue in the past year totalled $10.74 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.